undamentalytics Newsletter
Sign in

Adagio Medical Holdings, Inc. income statement

In fiscal 2025, Adagio Medical Holdings, Inc. reported revenue of $0, down 100.0% on the year before and net income of −$25.1m, or −$1.51 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2023Dec 20232025Dec 2025LTMJun 2026
Revenue000
Cost of revenue11—
Gross profit−1−1—
Research and development151110
Selling, general and administrative121110
Operating income−28−22−20
Interest expense233
Income before tax−37−25—
Income tax00—
Net income−37−25−27
Diluted EPS−$48.16−$1.51−$1.36
Diluted shares (average)—17m20m
EBITDA−27−21−19

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Adagio Medical Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Adagio Medical Holdings, Inc.